Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Accenture plcACN · Entity 2893 | Group Chief Exec - Health & PS | February 14, 2020 | February 19, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Accenture plc
Report date February 14, 2020 · Filed February 19, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A ordinary sharesSEC Table I · non-derivative | Direct | 22,474 |
Reported balance
After 2020-02-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-02-14 · Grant · Acquired 23 · Balance 22,474 F1: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. |
| Class A ordinary sharesSEC Table I · non-derivative | Direct | 22,469 |
Reported balance
After 2020-02-14 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2020-02-14 · Tax withholding · Disposed 5 · Balance 22,469 |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Accenture Holdings plc
Report date March 12, 2018 · Filed March 13, 2018
Section 16 reporting ended · disclosed 2018-03-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-03-12 transaction · row 1
1 source rowRow 1 · 2018-03-12 · Disposition to issuer · Disposed 2,000 · Balance 0 F1: On March 12, 2018, Accenture plc and Accenture Holdings plc obtained an order from the Irish High Court confirming the merger (the "Merger") of Accenture Holdings plc with and into Accenture plc. On March 13, 2018, the Merger became effective and Accenture plc became the successor of Accenture Holdings plc pursuant to the Merger and Accenture Holdings plc was dissolved without going into liquidation. Pursuant to the Merger, each holder of Accenture Holdings plc's ordinary shares (other than Accenture plc and Accenture Holdings plc itself) received one Class A ordinary share of Accenture plc in exchange for every one ordinary share of Accenture Holdings plc held by such holder at the effective time of the Merger. The transaction did not alter the proportionate interests of security holders. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 12, 2018, Accenture plc and Accenture Holdings plc obtained an order from the Irish High Court confirming the merger (the "Merger") of Accenture Holdings plc with and into Accenture plc. On March 13, 2018, the Merger became effective and Accenture plc became the successor of Accenture Holdings plc pursuant to the Merger and Accenture Holdings plc was dissolved without going into liquidation. Pursuant to the Merger, each holder of Accenture Holdings plc's ordinary shares (other than Accenture plc and Accenture Holdings plc itself) received one Class A ordinary share of Accenture plc in exchange for every one ordinary share of Accenture Holdings plc held by such holder at the effective time of the Merger. The transaction did not alter the proportionate interests of security holders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2018 Filed Aug 7, 2018 20:18 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 1,930 | $160.36 | $309,486.12 |
DisclosureSEC source: 0001467373-18-000269 · wf-form4_153367311282740.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,588 F2 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $159.89 to $160.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 05, 2018 Filed Aug 7, 2018 20:18 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 164 | $159.95 | $26,231.80 |
DisclosureSEC source: 0001467373-18-000269 · wf-form4_153367311282740.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,518 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| July 05, 2018 Filed Jul 9, 2018 12:43 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 160 | $164.01 | $26,240.80 |
DisclosureSEC source: 0001467373-18-000240 · wf-form4_153114016503005.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,354 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| June 05, 2018 Filed Jun 6, 2018 20:41 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 164 | $159.71 | $26,191.62 |
DisclosureSEC source: 0001467373-18-000216 · wf-form4_152831765790110.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,194 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| May 15, 2018 Filed May 17, 2018 21:56 UTC | Accenture plc ACN · Entity 2893 | GrantAccenture plc Class A ordinary shares | 92 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-18-000200 · wf-form4_152659417179857.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,030 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| May 05, 2018 Filed May 8, 2018 12:34 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 173 | $152.15 | $26,322.38 |
DisclosureSEC source: 0001467373-18-000187 · wf-form4_152578286144335.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,938 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 20:40 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 600 | $153.79 | $92,275.02 |
DisclosureSEC source: 0001467373-18-000175 · wf-form4_152451597081782.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,765 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $153.23 to $154.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 20:40 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 1,262 | $152.61 | $192,588.39 |
DisclosureSEC source: 0001467373-18-000175 · wf-form4_152451597081782.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,365 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $152.20 to $153.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 05, 2018 Filed Apr 6, 2018 20:36 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 173 | $151.04 | $26,129.92 |
DisclosureSEC source: 0001467373-18-000157 · wf-form4_152304698141006.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,627 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| March 12, 2018 Filed Mar 13, 2018 20:20 UTC | Accenture plc ACN · Entity 2893 | Disposition to issuerOrdinary shares of Accenture Holdings plc · Derivative | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001467373-18-000134 · wf-form4_152097242654867.xml · derivative · entry 3 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A ordinary shares · 2,000 shares Expires not disclosed F4 · derivative.exercise_price: Accenture Holdings plc was a subsidiary of Accenture plc. Subject to certain contractual restrictions, Accenture Holdings plc was obligated, at the option of the Reporting Person, to redeem any outstanding Accenture Holdings plc ordinary shares at a redemption price per share generally equal to the market price of an Accenture plc Class A ordinary share at the time of the redemption, subject to anadjustment.Accenture Holdings plc could, at its option, pay the redemption price with cash or by delivering Accenture plc Class A ordinary shares. F1 · price: On March 12, 2018, Accenture plc and Accenture Holdings plc obtained an order from the Irish High Court confirming the merger (the "Merger") of Accenture Holdings plc with and into Accenture plc. On March 13, 2018, the Merger became effective and Accenture plc became the successor of Accenture Holdings plc pursuant to the Merger and Accenture Holdings plc was dissolved without going into liquidation. Pursuant to the Merger, each holder of Accenture Holdings plc's ordinary shares (other than Accenture plc and Accenture Holdings plc itself) received one Class A ordinary share of Accenture plc in exchange for every one ordinary share of Accenture Holdings plc held by such holder at the effective time of the Merger. The transaction did not alter the proportionate interests of security holders. F4 · derivative.exercise_date: Accenture Holdings plc was a subsidiary of Accenture plc. Subject to certain contractual restrictions, Accenture Holdings plc was obligated, at the option of the Reporting Person, to redeem any outstanding Accenture Holdings plc ordinary shares at a redemption price per share generally equal to the market price of an Accenture plc Class A ordinary share at the time of the redemption, subject to anadjustment.Accenture Holdings plc could, at its option, pay the redemption price with cash or by delivering Accenture plc Class A ordinary shares. F4 · derivative.expiration_date: Accenture Holdings plc was a subsidiary of Accenture plc. Subject to certain contractual restrictions, Accenture Holdings plc was obligated, at the option of the Reporting Person, to redeem any outstanding Accenture Holdings plc ordinary shares at a redemption price per share generally equal to the market price of an Accenture plc Class A ordinary share at the time of the redemption, subject to anadjustment.Accenture Holdings plc could, at its option, pay the redemption price with cash or by delivering Accenture plc Class A ordinary shares. Read SEC document |
| March 12, 2018 Filed Mar 13, 2018 20:20 UTC | Accenture plc ACN · Entity 2893 | Disposition to issuerClass X ordinary shares | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-18-000134 · wf-form4_152097242654867.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Reflects the redemption of Accenture plc Class X ordinary shares by and at the election of Accenture plc. F3 · price: Redemption price per share equal to par value of $0.0000225. Read SEC document |
| March 12, 2018 Filed Mar 13, 2018 20:20 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001467373-18-000134 · wf-form4_152097242654867.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,454 F1 · price: On March 12, 2018, Accenture plc and Accenture Holdings plc obtained an order from the Irish High Court confirming the merger (the "Merger") of Accenture Holdings plc with and into Accenture plc. On March 13, 2018, the Merger became effective and Accenture plc became the successor of Accenture Holdings plc pursuant to the Merger and Accenture Holdings plc was dissolved without going into liquidation. Pursuant to the Merger, each holder of Accenture Holdings plc's ordinary shares (other than Accenture plc and Accenture Holdings plc itself) received one Class A ordinary share of Accenture plc in exchange for every one ordinary share of Accenture Holdings plc held by such holder at the effective time of the Merger. The transaction did not alter the proportionate interests of security holders. Read SEC document |
| March 12, 2018 Filed Mar 13, 2018 16:27 UTC | Accenture Holdings plc NONE · Entity 168328 | Disposition to issuerOrdinary Shares | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001647339-18-000007 · wf-form4_152097283790303.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: On March 12, 2018, Accenture plc and Accenture Holdings plc obtained an order from the Irish High Court confirming the merger (the "Merger") of Accenture Holdings plc with and into Accenture plc. On March 13, 2018, the Merger became effective and Accenture plc became the successor of Accenture Holdings plc pursuant to the Merger and Accenture Holdings plc was dissolved without going into liquidation. Pursuant to the Merger, each holder of Accenture Holdings plc's ordinary shares (other than Accenture plc and Accenture Holdings plc itself) received one Class A ordinary share of Accenture plc in exchange for every one ordinary share of Accenture Holdings plc held by such holder at the effective time of the Merger. The transaction did not alter the proportionate interests of security holders. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 21:34 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 166 | $158.33 | $26,281.95 |
DisclosureSEC source: 0001467373-18-000125 · wf-form4_152037207400397.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,454 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 14:09 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 169 | $155.00 | $26,195.00 |
DisclosureSEC source: 0001467373-18-000070 · wf-form4_151801255749507.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,288 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 21:29 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 510 | $160.34 | $81,770.85 |
DisclosureSEC source: 0001467373-18-000061 · wf-form4_151786615586005.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,119 Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 21:24 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 4,776 | $158.55 | $757,254.86 |
DisclosureSEC source: 0001467373-18-000039 · wf-form4_151553305369950.xml · nonDerivative · entry 5 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,629 F3 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F5 · price: The transaction was executed in multiple trades at prices ranging from $158.14 to $158.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 21:24 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 700 | $157.64 | $110,347.02 |
DisclosureSEC source: 0001467373-18-000039 · wf-form4_151553305369950.xml · nonDerivative · entry 4 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,405 F3 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F4 · price: The transaction was executed in multiple trades at prices ranging from $157.03 to $158.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:24 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 903 | $156.93 | $141,703.28 |
DisclosureSEC source: 0001467373-18-000039 · wf-form4_151553305369950.xml · nonDerivative · entry 3 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,105 Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:24 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 2,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-18-000039 · wf-form4_151553305369950.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,008 F2 · shares: Grant made pursuant to the Voluntary Equity Investment Program. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 21:24 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 2,042 | $156.93 | $320,440.85 |
DisclosureSEC source: 0001467373-18-000039 · wf-form4_151553305369950.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,859 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 21:23 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 767 | $153.83 | $117,983.78 |
DisclosureSEC source: 0001467373-18-000018 · wf-form4_151501461932236.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,817 Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 21:23 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 4,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-18-000018 · wf-form4_151501461932236.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,584 F1 · kind: Represents a grant of restricted share units awarded under the Accenture plc Amended and Restated 2010 Share Incentive Plan. Read SEC document |
| December 05, 2017 Filed Dec 7, 2017 13:57 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 178 | $147.63 | $26,278.59 |
DisclosureSEC source: 0001467373-17-000495 · wf-form4_151265501462150.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,709 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:23 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 47 | $144.34 | $6,783.86 |
DisclosureSEC source: 0001467373-17-000476 · wf-form4_151095379336550.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,531 Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:23 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 187 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000476 · wf-form4_151095379336550.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,578 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 05, 2017 Filed Nov 7, 2017 21:21 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 182 | $143.90 | $26,188.89 |
DisclosureSEC source: 0001467373-17-000462 · wf-form4_151008965469664.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,391 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 4,698 | $139.95 | $657,485.10 |
DisclosureSEC source: 0001467373-17-000448 · wf-form4_150913594710095.xml · nonDerivative · entry 5 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,209 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 10,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000448 · wf-form4_150913594710095.xml · nonDerivative · entry 4 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,907 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 85 | $140.96 | $11,981.60 |
DisclosureSEC source: 0001467373-17-000448 · wf-form4_150913594710095.xml · nonDerivative · entry 3 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,554 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 1,602 | $140.26 | $224,688.67 |
DisclosureSEC source: 0001467373-17-000448 · wf-form4_150913594710095.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,639 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $139.88 to $140.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 1,400 | $139.75 | $195,650.00 |
DisclosureSEC source: 0001467373-17-000448 · wf-form4_150913594710095.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,241 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $138.87 to $139.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 06, 2017 Filed Oct 10, 2017 13:00 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 637 | $136.03 | $86,649.71 |
DisclosureSEC source: 0001467373-17-000423 · wf-form4_150764040066517.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,641 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $135.83 to $136.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 05, 2017 Filed Oct 10, 2017 12:56 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 193 | $135.82 | $26,213.26 |
DisclosureSEC source: 0001467373-17-000417 · wf-form4_150764016317412.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,278 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 20:34 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 203 | $129.75 | $26,338.24 |
DisclosureSEC source: 0001467373-17-000377 · wf-form4_150473008479797.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,085 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| August 16, 2017 Filed Aug 16, 2017 20:51 UTC | Accenture plc ACN · Entity 2893 | GiftOrdinary shares of Accenture Holdings plc · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000374 · wf-form4_150291665894796.xml · derivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Class A ordinary shares · 2,000 shares Expires not disclosed F3 · derivative.exercise_price: Accenture Holdings plc is a subsidiary of Accenture plc. Subject to certain contractual restrictions, Accenture Holdings plc is obligated, at the option of the Reporting Person, to redeem any outstanding Accenture Holdings plc ordinary shares at a redemption price per share generally equal to the market price of an Accenture plc Class A ordinary share at the time of the redemption, subject to an adjustment. Accenture Holdings plc may, at its option, pay the redemption price with cash or by delivering Accenture plc Class A ordinary shares. F3 · derivative.exercise_date: Accenture Holdings plc is a subsidiary of Accenture plc. Subject to certain contractual restrictions, Accenture Holdings plc is obligated, at the option of the Reporting Person, to redeem any outstanding Accenture Holdings plc ordinary shares at a redemption price per share generally equal to the market price of an Accenture plc Class A ordinary share at the time of the redemption, subject to an adjustment. Accenture Holdings plc may, at its option, pay the redemption price with cash or by delivering Accenture plc Class A ordinary shares. F3 · derivative.expiration_date: Accenture Holdings plc is a subsidiary of Accenture plc. Subject to certain contractual restrictions, Accenture Holdings plc is obligated, at the option of the Reporting Person, to redeem any outstanding Accenture Holdings plc ordinary shares at a redemption price per share generally equal to the market price of an Accenture plc Class A ordinary share at the time of the redemption, subject to an adjustment. Accenture Holdings plc may, at its option, pay the redemption price with cash or by delivering Accenture plc Class A ordinary shares. Read SEC document |
| August 16, 2017 Filed Aug 16, 2017 20:51 UTC | Accenture plc ACN · Entity 2893 | OtherClass X ordinary shares | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000374 · wf-form4_150291665894796.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · kind: Reflects the redemption of Accenture plc Class X ordinary shares by and at the election of Accenture plc. F2 · price: Redemption price per share equal to par value of $0.0000225. Read SEC document |
| August 16, 2017 Filed Aug 16, 2017 16:52 UTC | Accenture Holdings plc NONE · Entity 168328 | GiftOrdinary shares of Accenture Holdings plc | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001647339-17-000013 · wf-form4_150291674273975.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · price: Reflects the redemption of Accenture Holdings plc ordinary shares at the redemption price determined in accordance with the Accenture Holdings plc Memorandum and Articles of Association. Read SEC document |
| August 05, 2017 Filed Aug 8, 2017 13:08 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 201 | $130.11 | $26,151.11 |
DisclosureSEC source: 0001467373-17-000366 · wf-form4_150219769965231.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,882 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| July 24, 2017 Filed Jul 25, 2017 12:12 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 4,808 | $128.05 | $615,685.56 |
DisclosureSEC source: 0001467373-17-000349 · wf-form4_150098476118561.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,681 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $127.62 to $128.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 11:46 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 437 | $127.36 | $55,656.32 |
DisclosureSEC source: 0001467373-17-000342 · wf-form4_150063756569659.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Grp Chief Exec-Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,489 Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 12:52 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 211 | $124.39 | $26,245.24 |
DisclosureSEC source: 0001467373-17-000320 · wf-form4_149943195177363.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Grp Chief Exec-Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,926 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 20:37 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 208 | $126.21 | $26,251.70 |
DisclosureSEC source: 0001467373-17-000265 · wf-form4_149678142617262.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Grp Chief Exec-Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,715 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| May 15, 2017 Filed May 16, 2017 20:12 UTC | Accenture plc ACN · Entity 2893 | GrantAccenture plc Class A ordinary shares | 111 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000241 · wf-form4_149496555067689.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Grp Chief Exec-Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,507 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| May 05, 2017 Filed May 8, 2017 20:12 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 217 | $121.14 | $26,287.92 |
DisclosureSEC source: 0001467373-17-000205 · wf-form4_149427433811317.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Grp Chief Exec-Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,396 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| April 06, 2017 Filed Apr 7, 2017 20:09 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 697 | $117.29 | $81,750.01 |
DisclosureSEC source: 0001467373-17-000186 · wf-form4_149159573340882.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Grp Chief Exec-Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,179 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $116.85 to $117.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 05, 2017 Filed Apr 6, 2017 20:13 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 222 | $118.29 | $26,260.38 |
DisclosureSEC source: 0001467373-17-000179 · wf-form4_149150960569649.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Grp Chief Exec-Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,876 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| March 05, 2017 Filed Mar 7, 2017 14:08 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 212 | $123.62 | $26,206.91 |
DisclosureSEC source: 0001467373-17-000144 · wf-form4_148889569841884.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Grp Chief Exec-Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,654 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 21:18 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 230 | $114.09 | $26,239.55 |
DisclosureSEC source: 0001467373-17-000073 · wf-form4_148641587453248.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Grp Chief Exec-Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,442 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 13:55 UTC | Accenture plc ACN · Entity 2893 | Tax withholdingClass A ordinary shares | 711 | $113.54 | $80,726.58 |
DisclosureSEC source: 0001467373-17-000056 · wf-form4_148613012173617.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Grp Chief Exec-Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,212 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.